SM
Sabby Management Portfolio holdings
AUM
$13M
This Quarter Return
-0.75%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$289M
AUM Growth
+$289M
(-42%)
Cap. Flow
-$11.7M
Cap. Flow
% of AUM
-4.04%
Top 10 Holdings %
Top 10 Hldgs %
39.85%
Holding
261
New
44
Increased
40
Reduced
58
Closed
60
Top Buys
| 1 |
Regeneron Pharmaceuticals
REGN
|
$11.3M |
| 2 |
Abbott
ABT
|
$10.4M |
| 3 |
Outlook Therapeutics
OTLK
|
$7.04M |
| 4 |
BPTH
Bio-Path Holdings Inc
BPTH
|
$5.95M |
| 5 |
SHPG
Shire pic
SHPG
|
$5.44M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$22.4M |
| 2 |
Plus Therapeutics
PSTV
|
$11.2M |
| 3 |
Biogen
BIIB
|
$6.55M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$3.88M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
$2.84M |
Sector Composition
| 1 | Healthcare | 85.34% |
| 2 | Industrials | 0.77% |
| 3 | Consumer Staples | 0.45% |
| 4 | Consumer Discretionary | 0.43% |
| 5 | Technology | 0.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ADMS
51
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $1.48M | 0.08% |
97,600
-102,290
| -51% | -$1.55M |
|
|
SRNE
52
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $1.42M | 0.07% |
253,805
-125,995
| -33% | -$705K |
|
53
Enlivex Therapeutics
ENLV
$25M
| $1.33M | 0.07% |
830,253
-303,684
| -27% | -$486K |
|
|
RIBT
54
DELISTED
RiceBran Technologies
RIBT
| $1.3M | 0.07% |
785,476
-231,982
| -23% | -$385K |
|
55
SCYNEXIS
SCYX
$35M
| $1.24M | 0.06% |
+572,928
| New | +$1.24M |
|
|
EXPR
56
DELISTED
Express, Inc.
EXPR
| $1.24M | 0.06% |
+16,386
| New | +$1.24M |
|
|
RXDX
57
DELISTED
Ignyta, Inc.
RXDX
| $1.22M | 0.06% |
225,000
+100,000
| +80% | +$542K |
|
|
TEAR
58
DELISTED
TearLab Corporation
TEAR
| $1.21M | 0.06% |
+1,882,347
| New | +$1.2M |
|
59
Collegium Pharmaceutical
COLL
$1.23B
| $1.2M | 0.06% |
101,410
+19,310
| +24% | +$229K |
|
60
Champions Oncology
CSBR
$96.5M
| $1.18M | 0.06% |
546,728
+251,400
| +85% | +$540K |
|
|
SRRA
61
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $1.17M | 0.06% |
+590,011
| New | +$1.17M |
|
62
Tonix Pharmaceuticals
TNXP
$241M
| $1.17M | 0.06% |
585,914
+200,666
| +52% | +$399K |
|
|
XTLB
63
XTL Biopharmaceuticals
XTLB
$10.6M
| $1.16M | 0.06% |
1,001,170
-39,024
| -4% | -$45.3K |
|
|
BCLI
64
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $1.15M | 0.06% |
476,719
-16,472
| -3% | -$39.7K |
|
|
CEMP
65
DELISTED
Cempra, Inc.
CEMP
| $1.06M | 0.06% |
64,065
-35,935
| -36% | -$592K |
|
66
Novavax
NVAX
$1.21B
| $1.04M | 0.05% |
+142,726
| New | +$1.04M |
|
|
IMUC
67
DELISTED
ImmunoCellular Therapeutics, Ltd.
IMUC
| $1.03M | 0.05% |
4,452,128
+40,757
| +0.9% | +$9.38K |
|
68
Kiora Pharmaceuticals
KPRX
$9.75M
| $1M | 0.05% |
+386,940
| New | +$1M |
|
|
ONCS
69
DELISTED
OncoSec Medical Incorporated
ONCS
| $997K | 0.05% |
608,052
-503,296
| -45% | -$825K |
|
|
IMMU
70
DELISTED
Immunomedics Inc
IMMU
| $986K | 0.05% |
+425,000
| New | +$986K |
|
71
Galectin Therapeutics
GALT
$283M
| $974K | 0.05% |
662,467
-410,298
| -38% | -$603K |
|
72
Rigel Pharmaceuticals
RIGL
$697M
| $972K | 0.05% |
+435,957
| New | +$972K |
|
|
ACUR
73
DELISTED
Acura Pharmaceuticals Inc
ACUR
| $959K | 0.05% |
518,444
-130,440
| -20% | -$241K |
|
74
Armata Pharmaceuticals
ARMP
$96.4M
| $951K | 0.05% |
+613,782
| New | +$951K |
|
|
KTOVW
75
DELISTED
Kitov Pharma Ltd. Warrants
KTOVW
| $944K | 0.05% |
1,210,785
+1,096,065
| +955% | +$855K |
|